Journey Medical (DERM) Other Non-Current Assets (2020 - 2024)
Journey Medical (DERM) posted Other Non-Current Assets of $6000.0 for Q3 2024, little changed on a QoQ basis from $6000.0 in Q2 2024, and little changed year-over-year from $6000.0 in Q4 2023.
Journey Medical (DERM) Other Non-Current Assets (2020 - 2024) Analysis & Trends
Journey Medical's Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $6000.0 for Q3 2024.
- Quarterly Other Non-Current Assets changed 0.0% year-over-year to $6000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $6000.0 (changed 0.0% YoY) and the FY2023 annual result came in at $6000.0, down 93.68% from the prior year.
- Other Non-Current Assets was $6000.0 for Q3 2024 at Journey Medical, roughly flat from $6000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $749000.0 in Q3 2021 and bottomed at $6000.0 in Q4 2020.
- A 5-year average of $103928.6 and a median of $47000.0 in 2020 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2021 — Other Non-Current Assets jumped 2400.0% — and 2023, when it sank 94.55%.
- Journey Medical's Other Non-Current Assets stood at $6000.0 in 2020, then soared by 2400.0% to $150000.0 in 2021, then tumbled by 36.67% to $95000.0 in 2022, then sank by 93.68% to $6000.0 in 2023, then changed by 0.0% to $6000.0 in 2024.
- Business Quant data shows DERM's Other Non-Current Assets at $6000.0 in Q3 2024, $6000.0 in Q2 2024, and $6000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 6,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 88,000.00 |
| Dec 31, 2022 | 95,000.00 |
| Sep 30, 2022 | 103,000.00 |
| Jun 30, 2022 | 110,000.00 |
| Mar 31, 2022 | 118,000.00 |
| Dec 31, 2021 | 150,000.00 |
| Sep 30, 2021 | 749,000.00 |
| Dec 31, 2020 | 6,000.00 |